.png)
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond will usually allow anyone to earn superior returns. That's not a secret, but it's easy to forget when dealing with an uncertain near term. Even turbulent times don't change this fact.For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: CRISPR Therapeutics (NASDAQ: CRSP) and Regeneron Pharmaceuticals (NASDAQ: REGN). These drugmakers have faced issues recently, and their shares have declined significantly over the trailing-12-month period. However, there may be considerable upside here for patient investors.Image source: Getty Images.Continue reading
Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond will usually allow anyone to earn superior returns. That's not a secret, but it's easy to forget when dealing with an uncertain near term. Even turbulent times don't change this fact.
For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: CRISPR Therapeutics (NASDAQ: CRSP) and Regeneron Pharmaceuticals (NASDAQ: REGN). These drugmakers have faced issues recently, and their shares have declined significantly over the trailing-12-month period. However, there may be considerable upside here for patient investors.
Image source: Getty Images.
